Drug desensitization

Immunology and Allergy Clinics of North America

Volumn 24, Issue 3, 2004, Pages 425-443

  Solensky, Roland ^a  

^a Oregon State University Oregon Health Science University College of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CLINDAMYCIN; CONTRAST MEDIUM; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DAPSONE; ERYTHROMYCIN; GENTAMICIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; LEVOFLOXACIN; NAFCILLIN; PARACETAMOL; PENICILLIN G; PENICILLOYL POLYLYSINE; SALBUTAMOL; SULFONAMIDE; TERFENADINE; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ALLERGIC REACTION; ANAPHYLAXIS; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; HEART ARRHYTHMIA; HEMOLYTIC ANEMIA; HEPATITIS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; LIVER NECROSIS; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; SKIN TEST; STEVENS JOHNSON SYNDROME; SYPHILIS; TINNITUS; TOXIC EPIDERMAL NECROLYSIS; TREMOR; VASCULITIS;

ANTI-BACTERIAL AGENTS; CROSS REACTIONS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HUMANS; SULFONAMIDES;

EID: 3042820716     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.03.008     Document Type: Review

References (64)

1. Rawlins M.D., Thompson W. Mechanisms of adverse drug reactions. Davies D.M. Textbook of adverse drug reactions. 1991;18-45 Oxford University Press, New York
2. DeShazo R.D., Kemp S.F. Allergic reactions to drugs and biologic agents. JAMA. 278:1997;1895-1906
3. Coombs R.R.A., Gell P.G.H. Classification of allergic reactions responsible for clinical hypersensitivity and disease. Gell P.G.H., Coombs R.R.A., Lachman P.J. Clinical aspects of immunology. 1975;761-781 Blackwell Scientific, Oxford
4. Gadde J., Spence M., Wheeler B., Adkinson N.F. Clinical experience with penicillin skin testing in a large inner-city STD Clinic. JAMA. 270:1993;2456-2463
5. Mendelson L.M., Ressler C., Rosen J.P., Selcow J.E. Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol. 73:1984;76-81
6. Sogn D.D., Evans R., Shepherd G.M., Casale T.B., Condemi J., Greenberger P.A., et al. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 152:1992;1025-1032
7. Parker C.W., deWeck A.L., Kern M., Eisen H.N. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity. J Exp Med. 115:1962;803-819
8. Levine B.B., Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzyl-penicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J Exp Med. 114:1961;875-904
9. Sullivan T.J., Wedner H.J., Shatz G.S., Yecies L.D., Parker C.W. Skin testing to detect penicillin allergy. J Allergy Clin Immunol. 68:1981;171-180
10. Bernstein I.L., Gruchalla R.S., Lee R.E., Nicklas R.A., Dykewicz M.S. Disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol. 83:1999;665-700
11. Sullivan T.J. Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol. 69:1982;500-508
12. Borish L., Tamir R., Rosenwasser L.J. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol. 80:1987;314-319
13. Green G.R., Peters G.A., Gerach J.E. Treatment of bacterial endocarditis in patients with penicillin hypersensitivity. Ann Intern Med. 67:1967;235-249
14. O'Donovan W.J., Klorfajn I. Sensitivity to penicillin: anaphylaxis and desensitization. Lancet. 2:1946;444-446
15. Pedersen-Bjergaard J. Specific hyposensitization of patients with penicillin allergy. Acta Allergol. 24:1969;333-361
16. Fellner M.J., VanHecke E., Rozan M., Baer R.L. Mechanisms of clinical desensitization in urticarial hypersensitivity to penicillin. J Allergy. 45:1970;55-61
17. Graybill J.R., Sande M.A., Reinarz J.A., Shapiro S.R. Controlled penicillin anaphylaxis leading to desensitization. South Med J. 67:1974;62-64
18. Gillman S.A., Korotzer J.L., Haddad Z.H. Penicillin desensitization: correlation of clinical and immunological events using an in vitro model. Clin Allergy. 2:1972;63-68
19. Stark B.J., Earl H.S., Gross G.N., Lumry W.R., Goodman E.L., Sullivan T.J. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol. 79:1987;523-532
20. Sullivan T.J., Yecies L.D., Shatz G.S., Parker C.W., Wedner H.J. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol. 69:1982;275-282
21. Wendel G.D., Stark B.J., Jamison R.B., Molina R.D., Sullivan T.J. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med. 312:1985;1229-1232
22. Chisholm C.A., Katz V.L., McDonald T.L., Bowes W.A. Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol. 14:1997;553-554
23. Ziaya P.R., Hankins G.D.V., Gilstrap L.C., Halsey A.B. Intravenous penicillin desensitization and treatment during pregnancy. JAMA. 256:1986;2561-2562
24. Herman R., Jick H. Cutaneous reaction rates to penicillins: oral versus parental. Cutis. 24:1979;232-234
25. Brown L.A., Goldberg N.D., Shearer W.T. Long-term ticarcillin desensitization by the continuous oral administration of penicillin. J Allergy Clin Immunol. 69:1982;51-54
26. Empedrad R., Darter A.L., Earl H.S., Gruchalla R.S. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol. 112:2003;629-630
27. Lantner R.R. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol. 96:1995;1001-1002
28. Chandler M.J., Ong R.C., Grammer L.C., Sullivan T.J. Detection, characterization, and desensitization of IgE to streptomycin [abstract]. J Allergy Clin Immunol. 89:1992;178
29. Earl H.S., Sullivan T.J. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol. 79:1987;477-483
30. Gea-Banacloche J.C., Metcalfe D.D. Ciprofloxacin desensitization. J Allergy Clin Immunol. 97:1996;1426-1427
31. Wong J.T., Ripple R.E., MacLean J.A., Marks D.R., Bloch K.J. Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. J Allergy Clin Immunol. 94:1994;189-194
32. Chopra N., Oppenheimer J., Derimanov G.S., Fine P.L. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol. 84:2000;633-635
33. Laurie S., Khan D. Successful clarithromycin desensitization in a macrolide-sensitive patient [abstract]. Ann Allergy Asthma Immunol. 84:2000;116
34. Ghosal S., Taylor C.J. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrob Chemother. 39:1997;556-557
35. Gorman S.K., Zed P.J., Dhingra V.K., Ronco J.J. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. Ann Pharmacother. 37:2003;513-516
36. Turvey S.E., Cronin B., Arnold A.D., Dioun A.F. Antibiotic desensitization for the allergic patient: 5 years of experience and practice [abstract]. J Allergy Clin Immunol. 111:2003;S288
37. Anne' S., Middleton E., Reisman R.E. Vancomycin anaphylaxis and successful desensitization. Ann Allergy. 73:1994;402-404
38. Lin R.Y. Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med. 150:1990;2197-2198
39. Carr A., Cooper D.A., Penny R. Allergic manifestations of human immunodeficiency virus (HIV) infection. J Clin Immunol. 11:1991;55-64
40. Coopman S.A., Johnson R.A., Platt R., Stern R.S. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 328:1993;1670-1674
41. Cribb A.E., Lee B.L., Trepanier L.A., Spielberg S.P. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev. 15:1996;9-50
42. Gordin F.M., Simon G.L., Wofsby C.B., Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 100:1984;495-499
43. Mitsuyasu R., Groopman J., Volberding P. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med. 308:1983;1535-1536
44. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis. 4:1982;426-428
45. Centers for Disease Control 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 46:1997;4-6
46. Absar N., Daneshvar H., Beall G. Desensitization to trimethoprim/ sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol. 93:1994;1001-1005
47. Gluckstein D., Ruskin J. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis. 20:1995;849-853
48. Nguyen M., Weiss P.J., Wallace M.R. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS. 9:1995;573-575
49. Belchi-Hernandez J., Espinosa-Parra F.J. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol. 76:1996;355-358
50. Kalanadhabhatta V., Muppidi D., Sahni H., Robles A., Kramer M. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Ann Allergy Asthma Immunol. 77:1996;394-400
51. Caumes E., Guermonprez G., Lecomte C., Katlama C., Bricaire F. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch Dermatol. 133:1997;465-469
52. Rich J.D., Sullivan T., Greineder D., Kazanjian P.H. Trimethoprim/ sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann Allergy Asthma Immunol. 79:1997;409-414
53. Ryan C., Madalon M., Wortham D.W., Graziano F.M. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature. Wis Med J. 97:1998;23-27
54. Demoly P., Messaad D., Sahla H., Fabre J., Faucherre V., Andre P., et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol. 102:1998;1033-1036
55. Bonfanti P., Pusterla L., Parazzini F., Libanore M., Cagni A.E., Franzetti M., et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. Biomed Pharmacother. 54:2000;45-49
56. Yoshizawa S., Yasuoka A., Kikuchi Y., Honda M., Gatanaga H., Tachikawa N., et al. A 5-day course of oral desensitization to trimethoprim/ sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol. 85:2000;241-244
57. Caumes E., Guermonprez G., Winter C., Katlama C., Bricaire F. Life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient. Clin Infect Dis. 23:1996;1313-1314
58. Kelly J.W., Dooley D.P., Lattuada C.P., Smith C.E. A severe unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin Infect Dis. 14:1992;1034-1039
59. Carr A., Penny R., Cooper D.A. Efficacy and safety of rechallenge with low-dose trimethoprim sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS. 7:1993;65-71
60. Choquet-Kastylevsky G., Vial T., Descotes J. Allergic adverse reactions to sulfonamides. Curr Allergy Asthma Rep. 2:2002;16-25
61. Knowles S., Shapiro L., Shear N.H. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Drug Saf. 24:2001;239-247
62. Patterson R., Bello A.E., Lefkowith F. Immunologic tolerability profile of celecoxib. Clin Ther. 21:1999;2065-2079
63. Koopmans P.P., van der Ven A.J., Vree T.B., van der Meer J.W. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS. 9:1995;217-222
64. Solensky R., Gruchalla R.S. Non-anaphylactic drug disorders. Zweiman B., Schwartz L.B. Inflammatory mechanisms in allergic diseases. 2001;411-433 Marcel Dekker, New York